- Exchange: Toronto
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Allon Therapeutics Inc
+ Add to WatchlistNPC:CN
0.0050 CAD 0.00000.00%As of 09:35:55 ET on 05/29/2013.
Trading has been suspended for NPC:CN
Snapshot for Allon Therapeutics Inc (NPC)
| Open: | - | Day's Range: | - | Volume: | 1,800 |
|---|---|---|---|---|---|
| Previous Close: | 0.0050 | 52wk Range: | 0.0050 - 0.5300 | 1-Yr Rtn: | - |
Key Statistics for NPC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPTSX | - |
| Earnings Per Share (ttm) | -0.0600 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 0.71 |
| Shares Outstanding (M) | 141.10 |
| 30 Day Average Volume | 113,944 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NPC
Company Profile & Key Executives for NPC
Allon Therapeutics Inc. is a drug discovery and development company focused on diseases and conditions of the central nervous system. The Company is developing novel neuroprotective central nervous system therapeutics with lead indications of Alzheimer's Disease and cognitive impairment.
| Gordon C McCauleyPresident/CEO | Matthew J CarlyleVP:Finance/CFO/Secretary |
| Alistair StewartVP:Commercial Research |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NPC News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page